T he results from a randomized clinical trial have demonstrated that a new decision-making tool can help men with prostate cancer (PCa), together with their medical teams, make choices regarding their treatment that improve their satisfaction with care. According to the researchers, the main goal of Patient Preferences for Prostate Cancer Care (PreProCare), a web-based decision tool, is to align the patient’s treatment options with the degree of risk posed by their disease while remaining in line with the patient’s values, unique needs, and preferences. The researchers believe that this patient-centered care approach reduces fears and regrets about therapy decisions while improving patient satisfaction with the result.

中文翻译：

---

前列腺癌工具可以帮助患者决定治疗

一项随机临床试验的结果表明，一种新的决策工具可以帮助前列腺癌 (PCa) 男性及其医疗团队做出有关治疗的选择，从而提高他们对护理的满意度。据研究人员称，前列腺癌护理患者偏好 (PreProCare) 是一种基于网络的决策工具，其主要目标是将患者的治疗选择与其疾病带来的风险程度保持一致，同时与患者的价值观保持一致、独特的需求和偏好。研究人员认为，这种以患者为中心的护理方法减少了对治疗决策的恐惧和遗憾，同时提高了患者对结果的满意度。